4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000112
EVP, Chief Scientific Officer sold 620 shares at $486.35 ($301,537)
- EVP, Chief Scientific Officer gave up 582 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bunnage Mark E. · EVP, Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-24 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −582 | $485.11 | $282,334 | 7,904 | D |
| 2026-02-25 | Sale : show line 2 in the form 10b5-1 | −620 | $486.35 | $301,537 | 7,284 | D |
| Open-market sales · 620 sh · avg $486.35 · $301,537 | ||||||
Loading xslF345X05/wk-form4_1772147216.xml…